PF4 and Thrombocytopenia: It was recently demonstrated that in several cases of individuals with thrombotic events and thrombocytopenia after ChAdOx1 nCoV-91 vaccination, who elicited antibody responses against platelet factor 4 (PF4)-heparin, also generated antibodies against PF4 independent of heparin (Figure 3) [11].